福泰制药2024财年第三财季实现净利润10.45亿美元,同比增加0.97%

市场透视
10 Nov 2024

11月10日,福泰制药(VRTX.US)公布财报,公告显示公司2024财年第三财季净利润为10.45亿美元,同比增加0.97%;其中营业收入为27.75亿美元,同比增加11.85%,每股基本收益为4.05美元。从资产负债表来看,福泰制药(VRTX.US)总负债66.09亿美元,其中短期债务0.00美元,资产负债比为3.37,流动比率为2.47。机构评级:截至2024年11月10日,当前有28家机构...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10